Download biomedica product list
FGF23 (intact) and FGF23 (C-terminal) can reliably be measured by ELISA
Today’s bulletin highlights a recent study investigating the association between bone quality, bone turnover, and anemia in a population-based study cohort. As FGF23 could be a link between the pathogenesis of anemia and osteoporosis, the researchers tested the hypothesis that FGF23 levels associate with hemoglobin levels and with bone quality.
Read more:
Interactions of Anemia, FGF-23, and Bone in Healthy Adults-Results From the Study of Health in Pomerania (SHIP). Hannemann A et al., J Clin Endocrinol Metab, 2021, Jan 1;106(1):e288-e299.
FGF23 (intact) and FGF23 (C-terminal) can reliably be measured by ELISA
√ CE-marked – for IVD use in the EU
√ CORRELATE with existing ELISA methods
√ Excellent stability in all matrices
√ For plasma & serum
√ HIGH QUALITY – fully validated according to international guidelines (ICH/FDA/EMEA)